Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma
Clinical trial NCT00117156 · COMPLETED
Trial details
- NCT number
- NCT00117156
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2008-10-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.